SPRING 2026
SPRING 2026
For cancer cells to grow and proliferate, they must be able to rapidly build and renew their outer membranes. These membrane structures are made of fatty molecules called lipids, but technical limitations have made it difficult to measure the dynamics…
Young minds are easily molded. Each new experience rewires a child’s brain circuitry, adding and removing synaptic connections between neurons. These wiring patterns become more stable with age, but biology has left some wiggle room to ensure that adult brains…
Seagrasses preserve our oceans and planet by absorbing carbon dioxide, calming rough waters, and offering a safe harbor for sea life. Unfortunately, these underwater meadows are under threat, and coastal restoration efforts to replant them often fail. In the waters…
Andrew “Drew” Senyei, MD, recently joined the Salk Institute’s Board of Trustees, bringing with him his decades of experience at the intersection of medicine, innovation, and investment. An inventor of the first FDA-approved test to predict preterm birth, now used…
The Salk Institute recently welcomed two new Nonresident Fellows: Andrew Dillin, PhD, and Christopher Glass, MD, PhD. The two scientists join a group of eminent scientific advisors who guide Salk’s leadership. Dillin is a professor at UC Berkeley and a…
Seven Salk Institute faculty members—Joseph Ecker, PhD, Ronald Evans, PhD, Rusty Gage, PhD, Christian Metallo, PhD, Satchin Panda, PhD, Reuben Shaw, PhD, and Kay Tye, PhD—along with research assistant Joseph Nery, were named to Clarivate’s 2025 Highly Cited Researchers list,…
Salk scientist Deepshika Ramanan, PhD, received a prestigious New Innovators Award from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), recognizing her creative and high-impact research on maternal immunity during pregnancy and…
Each year, Curebound, a San Diego-based philanthropic organization, awards one-time seed grants of $250,000 to early-phase cancer research projects that require interinstitutional collaboration. Salk scientists Tony Hunter, PhD, Dannielle Engle, PhD, Reuben Shaw, PhD, and Ronald Evans, PhD, received these…
Georgia Lattanzi, PhD, a researcher in the lab of Daniel Hollern, PhD, was awarded funding for her project investigating how tiny particles released by tumor cells activate B cells to coordinate stronger, more comprehensive immune attacks. CRI recognizes the next…
Tony Hunter, PhD, received the 2025 Dr. Paul Janssen Award for Biomedical Research in recognition of his “pioneering discoveries that inspired the development of more than 80 cancer therapies that continue to transform patient lives.” A committee of world-renowned scientists…
View flipbook
Download current issue
Archives